A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients
Status:
Completed
Trial end date:
2004-05-17
Target enrollment:
Participant gender:
Summary
This study is a 48-week study designed to evaluate the safety and efficacy of a fixed-dose
combination tablet administered once-a-day versus the individual tablets administered
twice-a-day within 3-drug combination regimens in ART (antiretroviral)-experienced HIV-1
infected patients.